• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 GROSHONG NXT CLEARVUE 4F SINGLE-LUMEN; CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 GROSHONG NXT CLEARVUE 4F SINGLE-LUMEN; CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS Back to Search Results
Model Number N/A
Device Problem Fluid/Blood Leak (1250)
Patient Problem Extravasation (1842)
Event Date 07/07/2022
Event Type  Injury  
Manufacturer Narrative
The device has not been returned to the manufacturer for evaluation.A lot history review (lhr) of redx0976 showed one other similar product complaint(s) from this lot number.
 
Event Description
It was reported on (b)(6) 2022, the catheter was placed by a professional nurse, and the process went smoothly.After filming, the catheter was shown to be in a normal position after implantation.On july 7th, the doctor ordered systemic chemotherapy.Before the infusion at 09:00, check the position of the puncture site, there is no exudate, and the blood return is smooth; when the shift is at noon, it is checked, the position is smooth, and there is no exudate in the puncture.Entering chemotherapy drugs, when the shift was handed over at 14:00 in the afternoon, the pipeline was in place, and the puncture site was dry and there was no exudate.The infusion went smoothly; at 15:45, when the nurses visited the puncture site, they saw exudate at the puncture site and immediately stopped the infusion.The static therapy group consulted and instructed the nurses to withdraw the catheter by 2 cm and perform flushing test.When flushing the tube, it was found that there were cracks and fluid leakage at 36-37 cm.Because the fluid exuded by the patient is a chemotherapy drug, the nurse has dealt with it in time.It is not ruled out that there may be local necrosis in the later stage.The patient has been extubated according to the doctor's order, and the patient was discharged from the hospital on july 8.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GROSHONG NXT CLEARVUE 4F SINGLE-LUMEN
Type of Device
CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
becky garcia
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key15254736
MDR Text Key298198229
Report Number3006260740-2022-03209
Device Sequence Number1
Product Code LJS
UDI-Device Identifier00801741086991
UDI-Public(01)00801741086991
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K034020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 08/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/18/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2023
Device Model NumberN/A
Device Catalogue Number7617405
Device Lot NumberREDX0976
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/02/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/01/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-